Pharmaceuticals - Community Register


List of referrals for human medicinal products

valproic acid/valproate

Product name: valproic acid/valproate
Also marketed in the EU under the name(s): Absenor, Acido valproico, Convulex, Convulsofin, Delepsine, Depakin, Depakine, Depakote, Depamag, Depamide, Deprakine, Diplexil, Epi-Chrono, Epilim, Episenta, Epival, Ergenyl, Espa-valept, Imaslav, Leptilan, Maphilep, Micropakine, Milzone, Natriumvalproaat, Natriumvalproaatti, Natriumvalproat, Navalac, Orfilept, Orfiril, Orlept, Petilin, Prodepa, Propymal, Sodio valproato, Sodium valproate, Tovaprox, Valberg, Valdia, Valepil, Valhel, Valpro, Valpro, Valproat, Valproate, Valproate de sodium, Valproate sodium, Valprodura, Valproic Acid, Valproim, Valproinsäure, ValproLEK, Valprostat, Valprotek, Valsil
Active substance: valproic acid/valproate
Indication: Bipolar disorder
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/08/2010 Referral EMEA/H/A-31/1163 (2010)6025 of 26/08/2010
12/04/2011 Corrigendum (2010)6025 corr of 08/04/2011